BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16141533)

  • 1. Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.
    Seki T; Wang MH; Miyata N; Laniado-Schwartzman M
    Biol Pharm Bull; 2005 Sep; 28(9):1651-4. PubMed ID: 16141533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A.
    Guo M; Roman RJ; Falck JR; Edwards PA; Scicli AG
    J Pharmacol Exp Ther; 2005 Nov; 315(2):526-33. PubMed ID: 16081682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors.
    Nguyen X; Wang MH; Reddy KM; Falck JR; Schwartzman ML
    Am J Physiol; 1999 Jun; 276(6):R1691-700. PubMed ID: 10362749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.
    Miyata N; Taniguchi K; Seki T; Ishimoto T; Sato-Watanabe M; Yasuda Y; Doi M; Kametani S; Tomishima Y; Ueki T; Sato M; Kameo K
    Br J Pharmacol; 2001 Jun; 133(3):325-9. PubMed ID: 11375247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats.
    Wang MH; Wang J; Chang HH; Zand BA; Jiang M; Nasjletti A; Laniado-Schwartzman M
    Am J Physiol Renal Physiol; 2003 Aug; 285(2):F295-302. PubMed ID: 12684227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
    Guo M; Roman RJ; Fenstermacher JD; Brown SL; Falck JR; Arbab AS; Edwards PA; Scicli AG
    J Pharmacol Exp Ther; 2006 Apr; 317(1):97-108. PubMed ID: 16352703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein.
    Wang MH; Stec DE; Balazy M; Mastyugin V; Yang CS; Roman RJ; Schwartzman ML
    Arch Biochem Biophys; 1996 Dec; 336(2):240-50. PubMed ID: 8954571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat.
    Schwartzman ML; da Silva JL; Lin F; Nishimura M; Abraham NG
    Nephron; 1996; 73(4):652-63. PubMed ID: 8856265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
    Orozco LD; Liu H; Perkins E; Johnson DA; Chen BB; Fan F; Baker RC; Roman RJ
    J Pharmacol Exp Ther; 2013 Jul; 346(1):67-74. PubMed ID: 23658377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor.
    Sato M; Ishii T; Kobayashi-Matsunaga Y; Amada H; Taniguchi K; Miyata N; Kameo K
    Bioorg Med Chem Lett; 2001 Dec; 11(23):2993-5. PubMed ID: 11714595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat.
    Hercule HC; Wang MH; Oyekan AO
    J Physiol; 2003 Sep; 551(Pt 3):971-9. PubMed ID: 12857783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of cytochrome P450 4A suppress angiogenic responses.
    Chen P; Guo M; Wygle D; Edwards PA; Falck JR; Roman RJ; Scicli AG
    Am J Pathol; 2005 Feb; 166(2):615-24. PubMed ID: 15681843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation.
    Mu Y; Klamerus MM; Miller TM; Rohan LC; Graham SH; Poloyac SM
    Drug Metab Dispos; 2008 Nov; 36(11):2324-30. PubMed ID: 18725506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury.
    Yousif MH; Benter IF; Roman RJ
    Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):33-41. PubMed ID: 19302554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels.
    Jiang M; Mezentsev A; Kemp R; Byun K; Falck JR; Miano JM; Nasjletti A; Abraham NG; Laniado-Schwartzman M
    Circ Res; 2004 Feb; 94(2):167-74. PubMed ID: 14670847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys.
    Wang MH; Guan H; Nguyen X; Zand BA; Nasjletti A; Laniado-Schwartzman M
    Am J Physiol; 1999 Feb; 276(2):F246-53. PubMed ID: 9950955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
    Mišir M; Renić M; Novak S; Mihalj M; Ćosić A; Vesel M; Drenjančević I
    Exp Physiol; 2017 Dec; 102(12):1596-1606. PubMed ID: 28940693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
    Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
    Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine.
    Wang MZ; Wu JQ; Bridges AS; Zeldin DC; Kornbluth S; Tidwell RR; Hall JE; Paine MF
    Drug Metab Dispos; 2007 Nov; 35(11):2067-75. PubMed ID: 17709372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion.
    Lv X; Wan J; Yang J; Cheng H; Li Y; Ao Y; Peng R
    Eur J Pharmacol; 2008 Oct; 596(1-3):118-26. PubMed ID: 18771665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.